ATE11217T1 - Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen. - Google Patents

Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen.

Info

Publication number
ATE11217T1
ATE11217T1 AT80303607T AT80303607T ATE11217T1 AT E11217 T1 ATE11217 T1 AT E11217T1 AT 80303607 T AT80303607 T AT 80303607T AT 80303607 T AT80303607 T AT 80303607T AT E11217 T1 ATE11217 T1 AT E11217T1
Authority
AT
Austria
Prior art keywords
cooh
compositions
antibiotic
strain
produces
Prior art date
Application number
AT80303607T
Other languages
English (en)
Inventor
William James Cunliffe
Elizabeth Anne Eady
Keith Thomas Holland
Original Assignee
William James Cunliffe
Elizabeth Anne Eady
Keith Thomas Holland
Boehringer Ingelheim International G.M.B.H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William James Cunliffe, Elizabeth Anne Eady, Keith Thomas Holland, Boehringer Ingelheim International G.M.B.H filed Critical William James Cunliffe
Application granted granted Critical
Publication of ATE11217T1 publication Critical patent/ATE11217T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/45—Staphylococcus epidermidis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/884—Staphylococcus epidermidis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT80303607T 1979-10-12 1980-10-13 Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen. ATE11217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7935534 1979-10-12
EP80303607A EP0027710B1 (de) 1979-10-12 1980-10-13 Antibiotische Substanzen, Verfahren zu deren Herstellung und deren Zusammensetzungen; Stamm von Staphylococcus epidermidis, welcher diese antibiotische Substanz produziert und deren Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE11217T1 true ATE11217T1 (de) 1985-02-15

Family

ID=10508479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80303607T ATE11217T1 (de) 1979-10-12 1980-10-13 Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen.

Country Status (7)

Country Link
US (2) US4448714A (de)
EP (1) EP0027710B1 (de)
JP (2) JPH0226640B2 (de)
AT (1) ATE11217T1 (de)
DE (1) DE3069980D1 (de)
DK (1) DK148748C (de)
WO (1) WO1981000962A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497730A (en) * 1984-04-03 1985-02-05 The United States Of America As Represented By The Department Of Health And Human Services Method for obtaining periplasmic proteins from bacterial cells using chloroform
DE58905744D1 (de) * 1988-07-15 1993-11-04 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
US5494808A (en) * 1994-09-15 1996-02-27 Merck & Co., Inc. Defined medium OMPC fermentation process
CA2265521C (en) * 1996-09-13 2009-06-09 Clemson University Anti-bacterial composition for treating acne
US6043219A (en) * 1996-09-19 2000-03-28 Kansas State University Research Foundation Broad spectrum chemotherapeutic peptide
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
EP3922264A4 (de) * 2019-02-04 2024-01-10 Riken Pharmazeutische zusammensetzung zur vorbeugung, verbesserung oder behandlung von hautkrankheiten
CN111763630A (zh) * 2019-03-27 2020-10-13 深圳微健康基因科技有限公司 表皮葡萄球菌及其用途
KR102390839B1 (ko) * 2020-06-19 2022-04-26 대한민국 항균활성을 갖는 스타필로코커스 유래 항균물질 혼합제 및 이의 용도
KR102627009B1 (ko) * 2021-12-17 2024-01-19 (주)메디톡스 피부 유해 세균에 대한 항세균 활성을 갖는 세균 균주, 및 이를 포함하는 약제학적 조성물
CN117511763A (zh) * 2022-08-05 2024-02-06 天康制药股份有限公司 一种表皮葡萄球菌高密度发酵培养基及其发酵方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178177B (nl) * 1952-05-09 Heijmans Wegenbouwmij Inrichting voor het aanbrengen van een wegmarkeringsstreep of dergelijke.
US3278378A (en) * 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
JPS595278B2 (ja) * 1976-07-10 1984-02-03 北里研究所（社団法人） 新規抗生物質ｐｏ−３５７物質及びその製造法並びに用途
DE2805813C3 (de) 1978-02-11 1984-02-23 Semikron Gesellschaft Fuer Gleichrichterbau U. Elektronik Mbh, 8500 Nuernberg l.PT 23.02.84 Halbleiteranordnung SEMIKRON Gesellschaft für Gleichrichterbau u. Elektronik mbH, 8500 Nürnberg, DE
DE2806813A1 (de) * 1978-02-17 1979-08-23 Hoechst Ag Manilosporine, neue cyclische polypeptid-antibiotica

Also Published As

Publication number Publication date
US4448714A (en) 1984-05-15
JPS56501363A (de) 1981-09-24
DE3069980D1 (en) 1985-02-28
US4588692A (en) 1986-05-13
WO1981000962A1 (en) 1981-04-16
DK148748B (da) 1985-09-16
EP0027710A1 (de) 1981-04-29
DK250981A (da) 1981-06-09
JPH0226640B2 (de) 1990-06-12
JPH02167069A (ja) 1990-06-27
DK148748C (da) 1986-02-24
EP0027710B1 (de) 1985-01-16
JPH046348B2 (de) 1992-02-05

Similar Documents

Publication Publication Date Title
ATE11217T1 (de) Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen.
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
DE69627704D1 (en) Protegrine
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
DE69429176D1 (en) Protegrine
EA200400944A1 (ru) Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
ATE249215T1 (de) Verwendung von app-modulatoren zur herstellung eines medikamentes zur behandlung der amyloidose
ES8507535A1 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
DE3483227D1 (de) Protein mit zellwachstumsstimulierender wirkung, dessen zusammensetzung und verfahren zu seiner herstellung.
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
DE69133509D1 (de) Verfahren zur herstellung von beta-lactamen
RU94044534A (ru) Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции
DE69839702D1 (de) Neue antimikrobielle polypeptide und verfahren für ihre verwendung.
DE59204480D1 (de) Verfahren zur Herstellung von tert.-Butoxycarbonyl-Gruppen tragenden organischen Verbindungen.
DE69128416T2 (de) Fibronektin bindendes Peptid
DE68924722D1 (de) Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
DE69104092D1 (de) Verfahren zur Herstellung von Amikacin-Vorläufern.
AU3674889A (en) Peptide molecules with activity against gram positive microorganisms
DE68906572D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
DE69032574D1 (de) Antibakterielle- und antimalariapeptide
GB1530921A (en) Desacylpepsidine and the preparation thereof
ATE46181T1 (de) Derivat von keratin, verfahren zu dessen herstellung und dieses enthaltende behandlungszusammensetzung.
PT65644A (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time